Open AccessOutcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments
Author(s) -
Francesco Tovoli,
Dante Pio Pallotta,
Vito Sansone,
M. Iavarone,
Massimo De Giorgio,
Luca Ielasi,
Giovan Giuseppe Di Costanzo,
Paolo Giuffrida,
Rodolfo Sacco,
Tiziana Pressiani,
Maria Francesca Donato,
Franco Trevisani,
S. Fagiuoli,
Fabio Piscaglia,
Alessandro Granito
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004271
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , liver transplantation , gastroenterology , transplantation , oncology , observational study , milan criteria , prospective cohort study , clinical trial , retrospective cohort study , surgery